Related Experiment Video
Updated: Aug 14, 2026
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Neuroendocrine effects of interferon alpha 2-a in healthy human subjects
A Pende1, N R Musso, C Vergassola
1Medical Pathology R and Clinical Methodology, ISMI, University of Genova, Italy.
Insights
Interferon alpha-2a significantly altered neuroendocrine markers, increasing norepinephrine and cortisol while decreasing lymphocyte beta 2-adrenoceptors. These findings highlight immune-neuroendocrine system interactions relevant to interferon therapy.
Area of Science:
- Immunology
- Neuroendocrinology
- Pharmacology
Background:
- Interferon alpha is increasingly used to treat various diseases.
- Understanding its systemic effects on neuroendocrine and immune markers is crucial.
- Previous research suggests links between the immune and neuroendocrine systems.
Purpose of the Study:
- To investigate the acute effects of interferon alpha-2a on catecholamines, beta-endorphin, cortisol, and lymphocyte beta 2-adrenoceptors.
- To explore the functional relationship between the neuroendocrine and immune systems following interferon administration.
Main Methods:
- Ten healthy volunteers received an intramuscular injection of interferon alpha-2a (3 x 10^8 IU).
- Plasma levels of norepinephrine, epinephrine, and beta-endorphin were measured.
- Serum cortisol levels and lymphocyte beta 2-adrenoceptor density were assessed.
Main Results:
- Interferon alpha-2a significantly increased plasma norepinephrine and serum cortisol levels.
- A significant decrease in lymphocyte beta 2-adrenoceptor density was observed.
- Epinephrine response was reduced, while beta-endorphin levels remained unchanged.
Conclusions:
- Interferon alpha-2a administration impacts both neuroendocrine and immune parameters.
- Results support the hypothesis of functional interactions between these systems.
- Findings may inform clinical applications and trial designs for interferon alpha therapies.
Abstract:
The acute effects of interferon alpha-2a (3 x 10 IU im) on catecholamine and immunoreactive beta endorphin plasma levels, cortisol serum levels and lymphocyte beta 2-adrenoceptor density were evaluated in ten healthy volunteers. Interferon induced a significant increase in plasma norepinephrine; there was an increased norepinephrine standing response, too. On the contrary, epinephrine standing response was reduced by interferon. Lymphocyte beta 2-adrenoceptors decreased significantly after interferon administration; dissociation constant of binding was unchanged. Cortisol serum levels increased significantly with respect to control test, whereas immunoreactive beta endorphin did not change. These results support the hypothesis of functional relationships between neuroendocrine and immune systems; moreover they may be useful in clinical trials given the administration of interferon alpha in an increasing number of diseases.
More Related Videos
10:10Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:30Inhibitors of Viral Protein Synthesis